Rhee Dong Keun, Park Su Hyung, Jang Yeun Kyu
Department of Biology, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea.
Genomics. 2008 Dec;92(6):419-28. doi: 10.1016/j.ygeno.2008.08.005. Epub 2008 Oct 9.
Comparative microarray analyses provided insight into understanding transcript changes during cancer progression; however, a reproducible signature underlying breast carcinogenesis has yet to be little available. We utilized gene expression profiling to define molecular signatures associated with transformation and cancer progression in a series of isogenic human breast cancer cell lines including a normal, benign, noninvasive and invasive carcinoma. Clustering analysis revealed four distinct expression patterns based on upregulation or downregulation patterns. These profiles proved quite useful for describing breast cancer tumorigenesis and invasiveness. Downregulation of TNFSF7, S100A4, S100A7, S100A8, and S100A9 (calcium-binding protein family), and upregulation of kallikrein-5 and thrombospondin-1 were associated with transformation and progression of breast cancer cells. Importantly, downregulation of the genes was reversed by treatment with silencing inhibitors, implying the potential roles of epigenetic inactivation in breast carcinogenesis. Exogenous expressions of S100A8 and S100A9 inhibit growth in benign and noninvasive carcinoma cells, suggesting their negative role in cell proliferation. The data presented here may facilitate the identification and functional analyses of prognostic biomarkers for breast cancer.
比较微阵列分析为理解癌症进展过程中的转录变化提供了见解;然而,乳腺癌发生过程中潜在的可重复特征仍然很少。我们利用基因表达谱来定义一系列同基因人乳腺癌细胞系(包括正常、良性、非侵袭性和侵袭性癌)中与转化和癌症进展相关的分子特征。聚类分析基于上调或下调模式揭示了四种不同的表达模式。这些图谱被证明对描述乳腺癌的肿瘤发生和侵袭性非常有用。TNFSF7、S100A4、S100A7、S100A8和S100A9(钙结合蛋白家族)的下调,以及激肽释放酶-5和血小板反应蛋白-1的上调与乳腺癌细胞的转化和进展相关。重要的是,用沉默抑制剂处理可逆转这些基因的下调,这意味着表观遗传失活在乳腺癌发生中具有潜在作用。S100A8和S100A9的外源性表达抑制良性和非侵袭性癌细胞的生长,表明它们在细胞增殖中起负作用。本文提供的数据可能有助于乳腺癌预后生物标志物的鉴定和功能分析。